Amoebiasis due to Entamoeba histolytica is an intestinal infection that can cause cramping, loose stools, and sometimes blood or mucus in the stool. Many people with amoebiasis have mild illness, but some develop liver abscesses with fever and right‑upper abdominal pain. It spreads through contaminated food or water, so travelers and people in areas with limited sanitation are most at risk. Most cases improve with prescription antiparasitic medicines, and fluids help prevent dehydration. The outlook is good with treatment, but severe amoebiasis can be life‑threatening if not treated promptly.
Overview
Amoebiasis due to entamoeba histolyticaSymptoms
Amoebiasis due to Entamoeba histolytica may cause cramping belly pain, watery or bloody diarrhea, gas, and urgency. Some have fever and fatigue; others have no symptoms. Severe cases can bring dehydration, liver pain, and fever from an abscess.
Outlook and prognosis
Most people with amoebiasis due to Entamoeba histolytica improve quickly with prompt, complete treatment and hydration. Recovery is usually within days, though energy and bowel habits may take longer to settle. Severe liver or bowel complications are uncommon with early care and follow‑up.
Causes and risk factors
Amoebiasis due to Entamoeba histolytica happens after ingesting parasite cysts from contaminated food, water, or oral-anal contact. Risk factors for amoebiasis include travel or residence in areas with poor sanitation, crowded institutions, immunosuppression, malnutrition, pregnancy, and extremes of age.
Genetic influences
Genetics plays a limited role in amoebiasis due to Entamoeba histolytica. Inherited differences in immune response may influence susceptibility, severity, and risk of complications, but exposure, sanitation, and nutrition are far more important drivers. Family clustering usually reflects shared environments.
Diagnosis
Clinicians review symptoms and travel/exposure history, then test stool with antigen detection or PCR; microscopy may support but cannot distinguish E. dispar. For suspected liver involvement, serology and ultrasound/CT aid the diagnosis of Amoebiasis due to Entamoeba histolytica.
Treatment and drugs
Amoebiasis due to Entamoeba histolytica is managed with prescription anti-parasitic medicines. Doctors often use a two-step approach: a tissue-active drug for invasive disease, followed by a gut-acting agent to clear lingering cysts and prevent relapse. Hydration, gentle nutrition, and symptom relief support recovery.
Symptoms
Many people have no symptoms, while others develop abdominal cramps and loose stools that come and go. Symptoms vary from person to person and can change over time. The early symptoms of Amoebiasis due to Entamoeba histolytica often look like mild diarrhea, bloating, or fatigue and can progress to bloody stools and fever. Less commonly, it can form a liver abscess with right‑upper abdominal pain and fever, sometimes without any diarrhea.
Many with amoebiasis have no symptoms. You can still pass the parasite to others through stool. Good handwashing and safe food and water reduce spread.
Loose or more frequent stools are common. Stools may be watery and urgent. This can alternate with days that feel normal.
Cramping or aching belly pain often sits low in the abdomen. Pain may ease after a bowel movement. It can return in waves through the day.
Mucus or streaks of blood can appear in stool with amoebiasis. This suggests inflammation in the colon. Heavy bleeding or many stools in a day needs prompt care.
How people usually first notice Amoebiasis due to entamoeba histolytica?
People usually first notice amoebiasis from Entamoeba histolytica when diarrhea lingers longer than a typical “stomach bug,” often with cramping, bloating, and fatigue. Blood or mucus in the stool, low‑grade fever, and the urge to pass stool even when little comes out (tenesmus) can be early warning signs, especially after recent travel to or residence in areas with limited sanitation. Some notice the illness only after dehydration, weight loss, or persistent abdominal pain develops, prompting a medical visit and stool testing.
Types of Amoebiasis due to entamoeba histolytica
Amoebiasis due to Entamoeba histolytica can show up in a few distinct ways, from no symptoms at all to severe disease. People may notice different sets of symptoms depending on their situation. Understanding the main types of amoebiasis helps explain why one person has mild stomach cramping while another develops liver pain or fever—these are recognized clinical variants rather than separate infections. Here are the main types to know about:
Asymptomatic infection
The parasite lives in the gut without causing noticeable symptoms. People may carry and pass cysts in stool, which can spread infection. This form may last weeks to months unless treated.
Mild intestinal disease
Loose stools, mild cramping, and occasional mucus can occur. Many feel generally unwell but can still go about daily life. Symptoms may come and go.
Amoebic dysentery
Frequent, painful stools with blood and mucus develop. Belly pain and fever are common, and dehydration can set in quickly. This is a more severe intestinal form that needs prompt care.
Liver abscess
Fever, right‑upper belly or shoulder pain, and feeling very unwell are typical. The parasite spreads from the intestine to the liver, forming a pocket of pus. Some have cough or chest discomfort if the abscess is near the diaphragm.
Other extraintestinal spread
Rarely, infection reaches the lungs, brain, or skin. Symptoms depend on the organ involved, such as chest pain or breathing trouble if the lungs are affected. These variants of amoebiasis are uncommon but serious.
What genetics can tell you about symptoms
Certain HLA gene patterns and variants affecting innate immune receptors can make some people more likely to develop severe amoebiasis symptoms like abdominal pain, bloody diarrhea, and liver abscesses. These genetic differences can weaken early defenses, allowing Entamoeba histolytica to invade tissues more easily.
Causes and risk factors
Infection spreads through food or water contaminated with stool, especially where sanitation is poor.
Some risks are modifiable (things you can change), others are non-modifiable (things you can’t).
Travel or living in endemic areas, crowded housing, and oral-anal sex raise risk.
Lower stomach acid, malnutrition, pregnancy, alcohol misuse, steroid medicines, and weak immunity increase severe disease.
There is no specific inherited risk for Amoebiasis due to Entamoeba histolytica, and early symptoms of Amoebiasis due to Entamoeba histolytica are more likely after travel or unsafe water.
Environmental and biological risk factors
Amoebiasis due to Entamoeba histolytica happens when the parasite reaches the gut, usually through contaminated water or food. Doctors often group risks into internal (biological) and external (environmental). These risks can exist long before any early symptoms of amoebiasis due to Entamoeba histolytica are noticed. Below are key environmental and biological factors that can raise the chance of infection or more serious illness.
Drinking or using untreated water can carry hardy E. histolytica cysts into the gut. Water for ice, toothbrushing, or rinsing foods can be a source when supplies are not safely treated.
Raw fruits and vegetables washed with unsafe water can carry the parasite. Foods prepared in settings with limited sanitation or refrigeration can be contaminated before eating.
Inadequate sewage disposal and lack of safe toilets allow feces to contaminate water and surfaces. This environmental contamination increases the chance of swallowing infectious cysts during daily activities.
Living in or traveling to areas where amoebiasis is common raises exposure risk. Risk is higher in tropical and subtropical regions where sanitation systems are strained.
Genetic risk factors
There’s no single “genetic cause” of amoebiasis due to Entamoeba histolytica, but inherited differences in immune signaling can shape who gets infected and who develops more severe illness, like liver abscess. Researchers have identified several host gene variants that affect how the gut lining and immune cells respond to this parasite. Understanding genetic risk factors for amoebiasis due to Entamoeba histolytica can help explain why some people get sicker than others. Risk is not destiny—it varies widely between individuals.
Leptin receptor variants: Changes in the leptin receptor (LEPR), including the common Q223R variant, have been linked to higher odds of symptomatic infection and diarrhea. Leptin helps keep the gut barrier strong and directs immune responses, so weaker signaling may make invasion easier. Some studies connect this variant to more frequent or more severe illness.
CREM gene variants: Variants near the CREM gene have been associated with increased risk of E. histolytica–related diarrhea. CREM influences immune signaling in the intestine, which can alter how strongly the gut responds to the parasite. This pathway overlaps with genes tied to other inflammatory gut conditions.
HLA class II types: Certain HLA class II alleles can raise or lower susceptibility to amoebiasis due to Entamoeba histolytica, including risk of liver abscess. These genes shape antigen presentation and the quality of T‑cell responses. Patterns vary by ancestry and study population.
Mannose-binding lectin: Variants in the MBL2 gene can lead to lower levels of mannose-binding lectin, a protein that tags microbes for clearance. Some reports link low-activity MBL2 variants with higher risk of invasive amoebiasis, such as liver abscess. Evidence differs across studies and populations.
Lifestyle risk factors
Amoebiasis due to entamoeba histolytica is mostly acquired through fecal–oral transmission, so everyday habits around eating, drinking, hygiene, travel, and sex matter. The main lifestyle risk factors for Amoebiasis due to entamoeba histolytica relate to how food is prepared, what water you drink, and how consistently you wash hands. Choosing safer options and consistent hygiene can markedly lower your chances of infection.
Drinking tap, well, or unboiled water in endemic areas can carry cysts that cause infection. Use bottled, sealed, or boiled water for drinking and toothbrushing.
Eating raw vegetables, salads, or fruits washed with unsafe water can transmit cysts. Peel fruits yourself or wash produce with safe water before eating.
Buying food from vendors with questionable hygiene or eating lukewarm dishes raises risk. Prefer freshly cooked foods served piping hot and prepared in clean conditions.
Skipping handwashing after using the toilet, changing diapers, or before eating increases transmission. Wash with soap and safe water for at least 20 seconds or use alcohol-based sanitizer when water is unavailable.
Risk prevention
Day to day, preventing amoebiasis due to Entamoeba histolytica mostly comes down to safe water, food, and hygiene—especially during travel or close-contact exposure. Prevention isn’t about perfection, it’s about small steps that add up. There’s no vaccine, so reducing exposure and treating infections promptly are key. Knowing early symptoms of amoebiasis can also help you act quickly and avoid spreading it.
Use sealed bottled water or water you boil for 1 minute (3 minutes at high altitude). Avoid ice and drinks mixed with tap water.
Eat foods cooked hot and served immediately. Choose fruits you can peel, and avoid raw salads in high-risk areas.
Wash hands with soap and safe water for at least 20 seconds after toilet use and before eating. Use alcohol-based sanitizer if clean water isn’t available, but wash with soap and water when you can.
Use flush toilets or well-maintained latrines and dispose of stool safely. In areas with poor sanitation, avoid contact with untreated sewage and wash hands after diaper changes.
Transmission
The transmission of amoebiasis due to Entamoeba histolytica happens when microscopic cysts from an infected person’s stool reach another person’s mouth—most often through contaminated water or food, or from unwashed hands after using the toilet or changing diapers. It can also spread during sexual contact that involves oral–anal exposure. Many people with amoebiasis have no symptoms yet still pass cysts, which can survive outside the body for days, so household or community spread is possible where sanitation is limited. It is not spread by casual contact like hugging or through the air; overall, it’s moderately infectious, with the highest risk in settings with unsafe water, poor hand hygiene, or during specific sexual practices.
When to test your genes
Amoebiasis is an infection, not inherited, so routine genetic testing isn’t needed to diagnose or treat it. Consider genetic testing only if you have repeated severe infections or complications and your care team suspects an underlying immune-system disorder that might change prevention or therapy. Otherwise, stool tests and imaging guide care far more effectively.
Diagnosis
When amoebiasis due to Entamoeba histolytica causes stomach pain, frequent loose stools, or blood and mucus in stool, these day-to-day changes often prompt a medical visit. Doctors usually begin with your symptoms, travel history, and a physical exam before ordering tests. If liver pain, fever, or weight loss are present, your provider may also look for signs of a liver abscess. You may hear your clinician explain how amoebiasis is diagnosed step by step, starting with stool tests and adding imaging or blood tests if needed.
Your clinician asks about recent travel, food and water exposures, and symptoms like fever, weight loss, or blood in stool. They also check for abdominal tenderness and signs that might point to liver involvement.
A stool sample is examined for cysts or trophozoites under the microscope. This can miss infections and cannot reliably tell E. histolytica from look‑alike, non‑harmful species.
Rapid tests can detect E. histolytica proteins in stool. These are more specific than microscopy and help distinguish it from nonpathogenic amoebas.
Molecular tests look for E. histolytica genetic material in stool. PCR can be highly sensitive and specific, especially useful when other tests are inconclusive.
Stages of Amoebiasis due to entamoeba histolytica
Amoebiasis due to entamoeba histolytica does not have defined progression stages. This infection can be silent, cause mild to severe bowel symptoms, or spread to the liver, and it may come on suddenly or develop over days rather than moving through set steps; early symptoms of amoebiasis often include cramping, loose stools, and fatigue. Different tests may be suggested to help confirm the diagnosis and check for complications like a liver abscess. Doctors often use stool studies and sometimes blood tests or imaging (such as ultrasound or CT) to diagnose and monitor amoebiasis, guided by your symptoms and travel or exposure history.
Outlook and prognosis
Looking at the long-term picture can be helpful. Most people with amoebiasis due to Entamoeba histolytica recover fully with prompt treatment, and once the parasite is cleared, day-to-day life usually returns to normal. Early care can make a real difference, especially if you seek help when early symptoms of amoebiasis—like cramping, mild diarrhea, or fatigue—first show up, rather than waiting until dehydration or blood in the stool develops.
The outlook is not the same for everyone, but most uncomplicated intestinal infections resolve without lasting problems. Severe illness is uncommon, yet it can happen if the infection spreads outside the gut, most notably to the liver. In those rare cases, people may develop a liver abscess that needs drainage and antibiotics; with proper care, survival is high, but without treatment the risk of serious complications and death rises. Mortality is now low in high-resource settings; when deaths occur, they’re typically linked to delayed diagnosis, coexisting illness, pregnancy, very young or older age, or lack of access to care.
Prognosis refers to how a condition tends to change or stabilize over time. After successful treatment, relapse is unusual unless someone is re-exposed in an area where amoebiasis is common. Travelers or people living in endemic regions can reduce future risk through safe food and water practices and, when appropriate, follow-up testing to confirm the parasite is gone. Talk with your doctor about what your personal outlook might look like, including any red flags to watch for and how to lower the chance of getting reinfected.
Long-term effects
Most people treated for amoebiasis due to Entamoeba histolytica recover fully with no lasting problems. Long-term effects vary widely, and they’re more likely after severe or delayed treatment. Some may notice ongoing bowel sensitivity, while a small number develop complications in the intestine, liver, or lungs. People who had severe early symptoms of amoebiasis may be at higher risk of lingering issues than those with mild illness.
Some people develop long-lasting irritable-bowel–type symptoms such as cramping, bloating, or loose stools. These may flare after certain foods or infections and then settle again.
A small number continue to have intermittent abdominal pain and diarrhea from persistent inflammation. This is more likely if treatment was incomplete or diagnosis was delayed.
Inflammation can rarely lead to strictures or a mass-like “amoeboma,” causing pain or bowel blockage. Symptoms may include constipation, narrow stools, or bloating.
After an amoebic liver abscess, some develop residual scarring and occasional right‑upper‑abdominal discomfort. Most regain normal liver function once the infection clears.
How is it to live with Amoebiasis due to entamoeba histolytica?
Living with amoebiasis due to Entamoeba histolytica can mean days to weeks of cramping, urgent diarrhea, and fatigue that interrupt work, school, and sleep, with some people also losing weight or feeling weak from dehydration. You may need quick access to bathrooms, extra fluids, and time to recover, and in rare cases with liver involvement, rest and medical follow-up become more intensive. People around you can be affected by disrupted routines and the need for careful hygiene—handwashing, safe food and water, and bathroom cleaning—to prevent spread. With prompt treatment and supportive care, most people improve steadily, and life returns to normal.
Treatment and drugs
Treatment for amoebiasis due to Entamoeba histolytica focuses on clearing the parasite and easing symptoms like stomach cramps and diarrhea. Doctors typically use two types of medicines: one to treat invasive infection in the tissues (such as the gut wall or liver) and another to clear lingering parasites in the intestine so the infection doesn’t come back or spread. If you have mild intestinal disease, you’ll usually receive an anti-amoebic drug followed by a “luminal” agent; more severe illness, dehydration, or liver abscess may require hospital care, intravenous fluids, and sometimes drainage of an abscess. Not every treatment works the same way for every person, so your dose and duration may be adjusted based on your symptoms, test results, and whether you’re pregnant or taking other medicines. Ask your doctor about the best starting point for you, and avoid alcohol with certain drugs used for amoebiasis.
Non-drug treatment
When amoebiasis due to Entamoeba histolytica flares, day-to-day life often revolves around bathroom trips, belly cramps, and staying hydrated enough to function. Alongside medicines, non-drug therapies can steady symptoms, protect your energy, and reduce the risk of spreading the infection at home. Pay attention to early symptoms of amoebiasis due to Entamoeba histolytica—like loose stools, nausea, and cramping—so you can start fluids and rest sooner. These steps won’t cure the infection, but they support recovery and limit complications.
Small, frequent sips of oral rehydration solution or salted broths replace lost fluid and minerals. This helps ease dizziness, dry mouth, and fatigue from diarrhea.
Choose bland, low-fat meals like rice, bananas, toast, soups, and yogurt if tolerated. Avoid alcohol, caffeine, spicy foods, and heavy fats until stools normalize.
Short rest periods reduce cramps and give your gut time to settle. Gradually return to normal activity as energy and hydration improve.
Wash hands with soap and water after toilet use and before eating or cooking. This lowers the chance of spreading amoebiasis due to Entamoeba histolytica to others in your household.
Your genes may have an impact on how drugs work for you
Your genes can affect how your liver processes anti-amoebic drugs like metronidazole, changing how quickly the medicine is cleared and how strong the side effects feel. Variants in enzymes and transporters may guide dose adjustments to improve cure rates and tolerability.
Pharmacological treatments
Treatment for Amoebiasis due to Entamoeba histolytica uses medicines that kill the parasite in body tissues, then a follow-up drug to clear it from the gut. People with early symptoms of amoebiasis or confirmed infection are usually started on a tissue-acting drug and then switched to a “luminal” medicine to prevent relapse. First-line medications are those doctors usually try first, based on how well they work and safety in most people. Your care team may adjust choices if you’re pregnant, have liver disease, or if the illness is severe.
Treats invasive amoebiasis in the intestines or liver tissue. It’s usually followed by a gut-clearing (luminal) drug to prevent recurrence. Avoid alcohol during treatment and for a few days after because it can make you feel very unwell.
Often used as a shorter course or single-dose option for invasive disease. A luminal agent is still needed afterward to clear the parasite from the gut. Avoid alcohol during treatment and for a few days after.
Cleans the parasite from the gut after metronidazole or tinidazole. It stays in the intestine and isn’t absorbed much, so it mainly works in the bowel. Many find it gentler on the body, though nausea or cramps can occur.
Another luminal medicine to finish clearing the parasite from the intestine. It’s taken after a tissue-acting drug to lower the risk of relapse. Upset stomach or headache can happen but often improve when the course is finished.
Genetic influences
Amoebiasis due to Entamoeba histolytica isn’t inherited; it’s picked up through contaminated food or water. Still, your genes can influence how likely you are to get sick after exposure and how severe the infection becomes, by shaping the way your gut lining and immune system respond to the parasite. Some people clear the organism without symptoms, while others develop inflammation of the colon or a liver abscess (a pocket of infection in the liver), and part of that difference may come from small variations in immune-response genes. Family clusters usually reflect shared exposure and living conditions more than genetics, though a pattern of unusually severe illness in close relatives could hint at an inherited tendency in how the immune system reacts. Having a genetic risk is not the same as having the disease itself. Genetics doesn’t change the early symptoms of amoebiasis—like diarrhea, stomach cramps, or blood in the stool—but it may influence who progresses to more invasive disease. There’s no routine genetic testing for this condition; prevention, clean water, and timely treatment remain the most important steps.
Is Amoebiasis due to entamoeba histolytica genetic?
Genetics plays a limited role in amoebiasis due to Entamoeba histolytica. Inherited differences in immune response may influence susceptibility, severity, and risk of complications, but exposure, sanitation, and nutrition are far more important drivers. Family clustering usually reflects shared environments.
Pharmacogenetics—how genetics influence drug effects
In treating Amoebiasis due to Entamoeba histolytica, doctors often use a nitroimidazole (metronidazole or tinidazole) to clear infection in the tissues, then a gut‑targeted antibiotic like paromomycin to remove parasites in the intestines. Not every difference in response is genetic, but small inherited differences in liver enzyme activity can change how quickly nitroimidazoles are cleared, which helps explain some genetic influences on metronidazole response in amoebiasis. If your body breaks these drugs down more slowly, you may notice more side effects; if it clears them faster, the medicine can seem less effective, though dosing is usually guided by symptoms, liver health, and drug interactions rather than genetic tests. Because paromomycin stays mostly in the gut and is minimally absorbed, genetic differences in drug‑metabolizing enzymes usually don’t affect its action or safety. There aren’t standard pharmacogenetic tests to choose or dose amoebiasis medicines today, and well‑validated gene–drug rules are limited. If you take other medicines with known pharmacogenetic guidance (for example, warfarin), your care team will factor in possible interactions when prescribing metronidazole or tinidazole.
Interactions with other conditions
People with amoebiasis due to Entamoeba histolytica often feel worse when another illness strains the immune system. HIV infection, malnutrition, diabetes, pregnancy, or medicines that suppress immunity (like high‑dose steroids or chemotherapy) can raise the risk of severe disease in the gut or of an amebic liver abscess; these are common risk factors for severe amoebiasis due to Entamoeba histolytica. A condition may “exacerbate” (make worse) symptoms of another, and a clear example is when steroids are started for presumed inflammatory bowel disease—if the diarrhea is actually from amoebiasis, steroids can trigger dangerous, rapidly worsening colitis. Existing liver problems, such as alcohol‑related liver disease or chronic viral hepatitis, can make an amebic liver abscess harder to detect and treat, and complications like rupture may be more likely. Co‑infections with other gut bugs, including bacterial dysentery or other parasites, can intensify dehydration and weight loss and make recovery slower. If there’s recent travel, residence in an area where amoebiasis is common, or long‑lasting diarrhea, clinicians often test for this infection before starting immune‑suppressing drugs to avoid these interactions.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Families and communities once noticed patterns of long, debilitating belly illness after travel or during seasons when water ran low or became muddy. People with amoebiasis often described weeks of cramping, urgent trips to the latrine, and fatigue that lingered after others recovered from common stomach bugs. Healers linked these bouts to food and water, passing down practical advice about boiling or avoiding certain wells, long before microscopes revealed the cause.
Throughout history, people have described severe “dysentery” with blood and mucus in stools, sometimes followed by sudden pain in the right side as the liver became tender and swollen. Early doctors grouped many diarrheal diseases together because the symptoms looked similar. As medical science evolved, careful notes from outbreaks in crowded cities, military camps, and seaports showed that not all dysentery behaved the same. Some cases were brief and contagious like bacterial infections; others were slow-burning, with complications that appeared weeks later.
First described in the medical literature as amoebic dysentery in the late 1800s, the illness was tied to a tiny parasite seen under the microscope in stool and tissue samples. Researchers noticed that people could carry the parasite without symptoms, spreading hardy cysts through contaminated water or unwashed hands. Over time, descriptions became more precise: the same organism could cause mild diarrhea in some and life‑threatening liver abscesses in others. This explained why communities saw both everyday sick days and rare, severe cases in the same households.
From early theories to modern research, the story of amoebiasis due to Entamoeba histolytica moved from bedside observation to laboratory proof. In the 20th century, staining methods and culture techniques helped distinguish E. histolytica from look‑alike, harmless amoebas that live in the gut. This shift mattered for patients, because treatment and public health responses depend on telling dangerous infections from harmless hitchhikers. In recent decades, awareness has grown that modern travel, urban crowding, and limited access to clean water keep amoebiasis present in many regions, while improved sanitation sharply reduces it elsewhere.
Advances in genetics fine‑tuned the picture. DNA tools showed that some amoebas once lumped together are actually separate species, clarifying why older studies sometimes disagreed about how severe the disease could be. Despite evolving definitions, the core lessons from history endure: safe water, sanitation, and handwashing protect communities; quick recognition and treatment prevent complications; and not everyone with the parasite becomes ill, which is why careful testing guides care. Looking back helps explain today’s advice on food and water safety for travelers and why health workers still consider amoebiasis when diarrhea lasts longer than expected or when a liver abscess appears without a clear cause.